Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Soluble HLA-G and HLA-G Bearing Extracellular Vesicles Affect ILT-2 Positive and ILT-2 Negative CD8 T Cells Complementary.

Frontiers in immunology - 1 Jan 2020

Schwich Esther, Hò Gia-Gia T, LeMaoult Joel, Bade-Döding Christina, Carosella Edgardo D, Horn Peter A, Rebmann Vera

Abstract excerpt

Tumor immune escape is associated with both, the expression of immune checkpoint molecules on peripheral immune cells and soluble forms of the human leukocyte antigen-G (HLA-G) in the blood, which are consequently discussed as clinical biomarker for disease status and outcome of cancer patients. HLA-G preferentially interacts with the inhibitory receptor immunoglobulin-like transcript (ILT) receptor-2 in the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, CD
Share to Biological Transport

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to CD8-Positive T-Lymphocytes

Share to Culture Media, Conditioned

Share to Extracellular Vesicles

Share to HLA-G Antigens

Share to Immunomodulation

Share to Leukocytes, Mononuclear

Source

Open in PubMed Open full text

Identifiers

PMID: 32973812
DOI: 10.3389/fimmu.2020.02046
PMCID: PMC7472666

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Soluble HLA-G and HLA-G Bearing Extracellular Vesicles Affect ILT-2 Positive and ILT-2 Negative CD8 T Cells Complementary.PMID 32973812Read ↗

The Role of HLA-G in Tumor Escape: Manipulating the Phenotype and Function of Immune CellsSemantic proximity Read ↗

First immunotherapeutic CAR-T cells against the immune checkpoint protein HLA-G.Semantic proximity Read ↗

HLA-G and Immune Evasion in Cancer CellsSemantic proximity Read ↗

The Dual Role of HLA-G in CancerSemantic proximity Read ↗

CD8+PD-1–ILT2+ T Cells Are an Intratumoral Cytotoxic Population Selectively Inhibited by the Immune-Checkpoint HLA-GSemantic proximity Read ↗

Extracellular Vesicles and Tumor-Immune Escape: Biological Functions and Clinical PerspectivesSemantic proximity Read ↗

The Molecular and Functional Characteristics of HLA-G and the Interaction with Its Receptors: Where to Intervene for Cancer Immunotherapy?Semantic proximity Read ↗

HLA-mediated tumor escape mechanisms that may impair immunotherapy clinical outcomes via T-cell activationSemantic proximity Read ↗

CAR-T-Derived Extracellular Vesicles: A Promising Development of CAR-T Anti-Tumor TherapySemantic proximity Read ↗

HLA-G: Too Much or Too Little? Role in Cancer and Autoimmune DiseaseSemantic proximity Read ↗

HLA-G engineering reprograms CAR-T cells with an immune privilegeSemantic proximity Read ↗

The transition from HLA-I positive to HLA-I negative primary tumors: the road to escape from T-cell responses.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.